Physics – Medical Physics
Scientific paper
Apr 2006
adsabs.harvard.edu/cgi-bin/nph-data_query?bibcode=2006apsp.conf..742m&link_type=abstract
ASTROPARTICLE, PARTICLE AND SPACE PHYSICS, DETECTORS AND MEDICAL PHYSICS APPLICATIONS . Proceedings of the 9th Conference . Held
Physics
Medical Physics
Scientific paper
A series of high specific activity accelerator-produced radionuclides in no-carrier-added (NCA) form, for uses in metabolic radiotherapy and for PET, has been investigated and produced at JRC-Ispra Cyclotron Laboratory. In this study we present, in particular, the NCA 211At/211gPo (LET = 130 eV.nm-1, t1/2= 7.214 h), produced by 209Bi(α,2n) reaction, with internal spike of gamma emitter 210At (e.g. negligible amount of 210Po as radiotoxic long-lived impurity), for high-LET targeted radiotherapy and immunoradiotherapy. A selective radiochemical separation, based on liquid/liquid extraction, of At radionuclides from Bi target and Po impurities has been developed. High resolution gamma, X and alpha spectrometric techniques have been adopted for quality controls of different radiochemical fractions.
Abbas K.
Alfassi Z. B.
Bonardi Mauro L.
Canella Lea
Groppi Flavia
No associations
LandOfFree
Alpha Cyclotron Production Studies of the Alpha Emitter 211AT/211gPO for High-Let Metabolic Radiotherapy does not yet have a rating. At this time, there are no reviews or comments for this scientific paper.
If you have personal experience with Alpha Cyclotron Production Studies of the Alpha Emitter 211AT/211gPO for High-Let Metabolic Radiotherapy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Alpha Cyclotron Production Studies of the Alpha Emitter 211AT/211gPO for High-Let Metabolic Radiotherapy will most certainly appreciate the feedback.
Profile ID: LFWR-SCP-O-1159517